Certican 0,5 mg tablete
| Name | Certican 0,5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-592546271 |
| Active Substance | everolimus |
| Composition | jedna tableta sadrži 0,5 mg everolimusa |
| Pharmaceutical Form | tableta |
| Manufacturer | Novartis Farmacéutica S.A., Barcelona, Španjolska Novartis Pharmaceuticals S.R.L., Targu Mures, Rumunjska |
| Marketing Authorisation Holder | Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, Hrvatska |
| Marketing Authorisation Date | 22.09.2016 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/115 |
| Registration Number | 381-12-01/38-16-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L04AH02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
